Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma
- 31 August 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 63 (2), e58-e59
- https://doi.org/10.1016/j.jaad.2009.10.052
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorJournal of Clinical Oncology, 2004
- Olmsted SyndromeThe American Journal of Dermatopathology, 2001
- Olmsted Syndrome: Report of Two New Cases and Literature ReviewThe Journal of Dermatology, 2000